You have 9 free searches left this month | for more free features.

HCV Coinfection

Showing 1 - 25 of 1,593

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HCV Coinfection, Liver Disease, HIV Trial in Baltimore (Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX],

Completed
  • HCV Coinfection
  • +2 more
  • Sofosbuvir/Velpatasvir/Voxilaprevir [SOF/VEL/VOX]
  • Sofosbuvir/Velpatasvir (SOF/VEL)
  • Baltimore, Maryland
    Johns Hopkins Hospital : The John G. Bartlett Specialty Practice
Feb 10, 2022

Hepatitis C, HIV Coinfection Trial in Chennai (Low intensity HCV treatment adherence support, Medium intensity HCV treatment

Recruiting
  • Hepatitis C
  • HIV Coinfection
  • Low intensity HCV treatment adherence support
  • +2 more
  • Chennai, Tamil Nadu, India
    YR Gaitonde Centre for AIDS Research and Education
May 12, 2022

Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)

Not yet recruiting
  • Liver Cirrhosis
  • Bunkyo-Ku, Tokyo, Japan
    Tokyo Metropolitan Komagome Hospital
Nov 29, 2023

Hepatitis C, People Who Inject Drugs, PWID Trial in New York (Accessible Care, Usual Care)

Completed
  • Hepatitis C
  • +3 more
  • Accessible Care
  • Usual Care
  • New York, New York
    Lower East Side Harm Reduction Center
Jul 27, 2021

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Hepatitis C, Chronic, HIV Infection Trial in Hai Phong, Ho Chi Minh City (Raltegravir, Efavirenz)

Completed
  • Hepatitis C, Chronic
  • HIV Infection
  • Hai Phong, Vietnam
  • +1 more
Jul 21, 2021

Control and Elimination Within Australia of Hepatitis C From

Active, not recruiting
  • Hepatitis C
  • +2 more
    • Burwood, New South Wales, Australia
    • +17 more
    Sep 6, 2021

    Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

    Completed
    • Chronic Hepatitis C Infection
    • +2 more
    • Hong Kong, Hong Kong, China
      Humanity and Health GI and Liver Centre
    Aug 27, 2021

    Liver Cirrhosis, Hepatocellular Carcinoma, HIV Trial in Spain

    Completed
    • Liver Cirrhosis
    • +3 more
      • La Línea de la Concepción, Cádiz, Spain
      • +7 more
      Feb 24, 2021

      RIBAvirin Plasma COncentrations in Chronic Hepatitis C Infection

      Completed
      • HCV Coinfection
      • Hepatitis C
        • Nijmegen, Gelderland, Netherlands
          Radboud University Medical Centre
        Dec 4, 2020

        HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR

        Recruiting
        • Hepatitis C Virus Infection
        • +2 more
          • Douliu, Taiwan
          • +6 more
          Feb 23, 2021

          Chronic Hepatitis C, Chronic Hepatitis B Trial in Beijing (Tenofovir Alafenamide 25 MG, Sofosbuvir / Velpatasvir)

          Recruiting
          • Chronic Hepatitis C
          • Chronic Hepatitis B
          • Tenofovir Alafenamide 25 MG
          • Sofosbuvir / Velpatasvir
          • Beijing, Beijing, China
            Peking University First Hospital
          Aug 2, 2021

          Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

          Completed
          • Hepatitis C Virus Infection
          • +3 more
          • ABT-493 coformulated with ABT-530
          • (no location specified)
          Jul 9, 2021

          End-stage Renal Disease, HCV Coinfection Trial in Assiut (Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet)

          Completed
          • End-stage Renal Disease
          • HCV Coinfection
          • Ombitasvir / Paritaprevir / Ritonavir /Ribavirin Oral Tablet
          • Assiut, Egypt
            Assiut University Hopsital
          Jan 8, 2020

          Hepatitis C Virus Infection

          Active, not recruiting
          • Hepatitis C
          • Hepatitis B
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Dec 30, 2022

            HIV Infection, Hepatitis C Infection Trial in Puerto Rico, United States (Nitazoxanide (NTZ), Pegylated interferon alfa-2a

            Completed
            • HIV Infection
            • Hepatitis C Infection
            • Nitazoxanide (NTZ)
            • +2 more
            • Birmingham, Alabama
            • +17 more
            Nov 2, 2021

            Hepatitis C Virus Infection Trial in Taiwan (LDV/SOF)

            Completed
            • Hepatitis C Virus Infection
            • Changhua, Taiwan
            • +10 more
            Feb 18, 2020

            HIV-1-infection, Hepatitis C, Chronic, Methadone Dependence Trial in Regina (Genvoya, Epclusa, Biktarvy)

            Unknown status
            • HIV-1-infection
            • +8 more
            • Regina, Saskatchewan, Canada
              Saskatchewan Health Authority
            Dec 23, 2019

            Hepatitis C in HIV Infected Injection Drug Users (IDUs)

            Completed
            • HIV Infection
            • Hepatitis C
              • Baltimore, Maryland
                Johns Hopkins Hospital
              Feb 17, 2022

              HCV Coinfection Trial in Afula (VEKIRAX, EXVIERA)

              Completed
              • HCV Coinfection
              • Afula, Israel
                Haemek medical center
              Aug 8, 2019

              Elimination of Hepatitis C Virus Among Users of Substances

              Not yet recruiting
              • Hepatitis C in Substance Users
              • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
              • (no location specified)
              Aug 14, 2022

              HIV Trial in Rome (Blood sample withdrawal)

              Recruiting
              • HIV
              • Blood sample withdrawal
              • Rome, Italy
                Catholic University of Sacred Heart
              Jul 23, 2019

              HIV, Hepatitis C Trial in United States (Ribavirin, Aldesleukin, Peginterferon alfa-2b)

              Completed
              • HIV Infections
              • Hepatitis C
              • Los Angeles, California
              • +7 more
              Oct 28, 2021

              HIV, Hepatitis C Trial in Puerto Rico, United States (Pegylated-Interferon Alfa 2b (PEG-IFN), Ribavirin (RBV), Boceprevir (BOC))

              Completed
              • HIV Infections
              • Hepatitis C
              • Pegylated-Interferon Alfa 2b (PEG-IFN)
              • +2 more
              • Birmingham, Alabama
              • +42 more
              Nov 2, 2021